ICU Medical, Inc.
NASDAQ:ICUIMedical - Instruments & Supplies
+$0.89 today
- Market cap
- $4.46B
- Beta
- 0.78
- P/E (TTM)
- 74.2
- EPS (TTM)
- $1.87
Volume 0.21M
Average 0.29M
ICUI Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
ICU Medical, Inc.NASDAQ: ICUI
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables growth accelerates
Q2 FY2026 accounts payables of $25.06M (cash outflow) rose 41.4% year over year, ahead of the -170.3% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at -42.8% a year.
Context
- Accounts payables amounted to 0.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +41.4% holds above the trailing-twelve-month pace of -170.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 7M USD
- Year-over-year change
- -44.2%
- 4-year CAGR
- +31.4%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7M | -44.2% |
| FY2024 | 2024-12-31 | 12.53M | +118.3% |
| FY2023 | 2023-12-31 | (68.3M) | -282.3% |
| FY2022 | 2022-12-31 | 37.47M | +1496.6% |
| FY2021 | 2021-12-31 | 2.35M | — |
Accounts Payables vs competitors
How ICUI compares with its peers on the latest reported figures
- ICUI's LTM Jun 2026 accounts payables of $12.29M is the 3rd largest of the 5 companies compared; the peer median is $8.57M.
- Its year-over-year change of -170.3% is the lowest of 4, against a peer median of +24.4%.
- Accounts payables amounts to 0.6% of revenue for ICUI, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $32M | -76.8% | — | 0.3% | |
| LTM Jun 2026 | $15.59M | +24.4% | -30.6% | 0.6% | |
| LTM Jun 2026 | $12.29M | -170.3% | -42.8% | 0.6% | |
| LTM Mar 2026 | $1.54M | +875.1% | -19.1% | 3.6% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ICUI) | $8.57M | +24.4% | -24.8% | 0.4% | |
Competitors are the stored peer set for ICUI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 103.14M | (74.29M) | (29.66M) | (117.69M) | 732K |
| Depreciation & Amortization | 89.7M | 235.15M | 228.77M | 219.51M | 200.74M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 27.34M | 36.03M | 40.56M | 46.88M | 55.76M |
| Change in Working Capital | 15.04M | (303.73M) | (135.6M) | (2.57M) | (90.04M) |
| Accounts Receivables | 13.76M | (19.15M) | 48.64M | (46.84M) | 8.88M |
| Inventory | 20.82M | (201.1M) | (6.08M) | 16.83M | (26.25M) |
| Accounts Payables | 2.35M | 37.47M | (68.3M) | 12.53M | 7M |
| Other Working Capital | (21.88M) | (120.96M) | (109.86M) | 14.92M | (79.67M) |
| Other Non-Cash Items | 32.33M | 44.71M | 62.12M | 57.9M | 12.66M |
| Operating Cash Flow | 267.54M | (62.13M) | 166.2M | 204.03M | 179.85M |
| Capital Expenditures | (81.17M) | (99.33M) | (93.67M) | (79.37M) | (88.04M) |
| Acquisitions (Net) | (14.45M) | (1.84B) | 0 | 0 | 0 |
| Purchases of Investments | (13.28M) | (3.4M) | 0 | 0 | 0 |
| Sales of Investments | 18M | 36.43M | 4.22M | 500K | 0 |
| Other Investing Activities | (12.41M) | (8.03M) | (8.28M) | (10.09M) | 210.27M |
| Investing Cash Flow | (90.69M) | (1.91B) | (87.95M) | (88.96M) | 122.23M |
| Debt Repayment | (607K) | 1.64B | (30.65M) | (52.15M) | (308.87M) |
| Common Stock Issued | 9.37M | 8.79M | 4.02M | 10.94M | 6.11M |
| Common Stock Repurchased | 0 | 0 | (9.35M) | (11.99M) | (8.77M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (25.64M) | (13.06M) | 0 | (2.6M) | 0 |
| Financing Cash Flow | (16.87M) | 1.64B | (35.98M) | (55.8M) | (311.53M) |
| Effect of Forex Changes | (3.25M) | (9.48M) | 3.16M | (4.93M) | 8.85M |
| Net Change in Cash | 156.73M | (344.04M) | 45.44M | 54.34M | (603K) |
| Free Cash Flow | 186.37M | (161.46M) | 72.53M | 124.66M | 91.8M |
ICU Medical, Inc.
NASDAQ:ICUI
Intrinsic Alpha fair value
Locked
Current Price
$178.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.